Evaluation of Hydro-Alcoholic Extract of Eclipta alba for its Multidrug Resistance Reversal Potential: An In Vitro Study

REFERENCES

• Farazi , P A and DePinho , R A . 2006 . Hepatocellular carcinoma pathogenesis: from genes to environment . Nature Reviews Cancer , 6 : 674 – 687 .
   PubMed Web of Science ®Google Scholar
• Juliano , R L and Ling , V . 1976 . A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants . Cancer Res , 43 : 2216 – 2218 .
   Google Scholar
• Leonard , G D , Fojo , T and Bates , S E . 2003 . The role of ABC transporters in clinical practice . Oncologist , 8 : 411 – 424 .
   PubMed Web of Science ®Google Scholar
• Gottesman , M M . 2002 . Mechanisms of cancer drug resistance . Ann Rev Med , 53 : 615 – 627 .
   PubMed Web of Science ®Google Scholar
• Castaing , M , Brouant , P , Loiseau , A , Santelli-Rouvier , C Santelli , M . 2000 . Membrane permeation by multidrug-resistance-modulators and non-modulators: effects of hydrophobicity and electric charge . J Pharm Pharmacol , 52 : 289 – 296 .
   PubMed Web of Science ®Google Scholar
• Thomas , H and Coley , H M . 2003 . Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting Pglycoprotein . Cancer Control , 10 : 159 – 165 .
   PubMedGoogle Scholar
• Arcamone , F M . 1998 . From the pigments of the actinomycetes to third generation antitumor anthracyclines . Biochimie , 80 : 201 – 206 .
   PubMed Web of Science ®Google Scholar
• Chaudhary , H , Dhuna , V , Singh , J , Kamboj , S S and Seshadri , S . 2011 . Evaluation of hydro-alcoholic extract of Eclipta alba for its anti-cancer potential: an in vitro study . J Ehnopharmacol , 136 : 363 – 367 .
   PubMed Web of Science ®Google Scholar
• Chaudhary , H , Arora , R , Vora , A , Jena , P K and Seshadri , S . 2012 . Evaluating the anti-cancer potential of hydro-alcoholic extract of Allium sativum L.: An in vitro and in vivo study . J Ethnobiol Traditional Med , 117 : 189 – 198 .
   Google Scholar
• Ananthi , J , Prakasam , A and Pugalendi , K V . 2003 . Antihyperglycemic activity of Eclipta alba leaf on alloxan-induced diabetic rats . Yale J Biol Med , 76 : 97 – 102 .
   PubMedGoogle Scholar
• Lee , M K , Ha , N R , Yang , H , Sung , S H Kim , G H . 2008 . Antiproliferative activity of triterpenoids from Ecliptaprostrata on hepatic stellate cells . Phytomed , 15 : 775 – 780 .
   PubMed Web of Science ®Google Scholar
• Kumari , C S , Govindasamy , S and Sukumar , E . 2006 . Lipid lowering activity of Ecliptaprostrata in experimental hyperlipidemia . J Ethnopharmacol , 105 : 332 – 335 .
   PubMed Web of Science ®Google Scholar
• Saxena , A K , Singh , B and Anand , K K . 1993 . Hepatoprotective effects of Eclipta alba on subcellular levels in rats . J Ethnopharmacol , 40 : 155 – 161 .
   PubMed Web of Science ®Google Scholar
• Singh , B , Saxena , A K , Chandan , B K , Agarwal , S G and Anand , K K . 2001 . In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves . Ind J Physiol Pharmacol , 45 : 435 – 441 .
   PubMedGoogle Scholar
• Dixit , S and Achar , M . 1979 . Bhringaraja (Eclipta alba Linn.) In the treatment of infective hepatitis . Curr Med Pract , 23 : 237 – 242 .
   Google Scholar
• Dixit , S and Achar , M . 1981 . Study of bhringaraja (Eclipta alba) therapy in jaundice in children . J Res Edu Ind Med , 2 : 96 – 100 .
   Google Scholar
• Murphy , R C , Hammarstrom , S , Samuelsson , B and Leukotriene , C . 1979 . A slow reacting substance from marine mastocytoma cells . The PNAS , 76 : 4275 – 4279 .
   PubMed Web of Science ®Google Scholar
• Hill , B A , Brown , P C , Preisegger , K H and Silverman , J A . 1996 . Regulation of mdr1b gene expression in Fischer, Wistar and Sprague–Dawley rats in vivo and in vitro . Carcinog , 17 : 451 – 457 .
   PubMed Web of Science ®Google Scholar
• Gant , T W , Silverman , J A , Bisgaard , H C , Burt , R K Marino , P A . 1991 . Regulation of 2-acetylaminofluorene and 3-methylcholajithrene-mediated induction of multidrug resistance and Regulation of rat mdrlb gene expression cytochrome P4501A gene family expression in primary hepatocyte cultures and rat liver . Molecular Carcinog , 4 : 499 – 509 .
   PubMed Web of Science ®Google Scholar
• Ambudkar , S V , Dey , S , Hrycyna , C A , Ramachandra , M Pastan , I . 1999 . Biochemical, cellular, and pharmacological aspects of the multidrug transporter . Ann Rev Pharmacol Toxicol , 39 : 361 – 398 .
   PubMed Web of Science ®Google Scholar
• Bradford , M MN . 1976 . A rapid and sensitive method forheguantation of microgram quantities of protein utilizing the principle of protein-dye binding . Anal Biochem , 172 : 248
   Google Scholar
• Liu , H , Zang , C , Fenner , M H , Liu , D Possinger , K . 2006 . Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD 18 . Blood , 107 : 3683 – 3692 .
   PubMed Web of Science ®Google Scholar
• Jedlitschky , G , Leier , I , Buchholz , U , Center , M and Keppler , D . 1994 . ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein . Cancer Res , 54 : 4833 – 4836 .
   PubMed Web of Science ®Google Scholar
• Schrenk , D , Gant , T W , Michalke , A , Orzechowski , A Silverman , J A . 1994 . Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells . Carcinog , 15 : 2541 – 2546 .
   PubMed Web of Science ®Google Scholar
• Thorgeirsson , S S , Silverman , J A , Gant , T W and Marino , P A . 1991 . Multidrug resistance gene family and chemical carcinogens . Pharmacol Ther , 49 : 283 – 292 .
   PubMed Web of Science ®Google Scholar
• Ferry , D R , Traunecker , H and Kerr , D J . 1996 . Clinical trials of P-glycoprotein reversal in solid tumours . Euro J Cancer , 32A : 1070 – 1081 .
   PubMed Web of Science ®Google Scholar